Management tracks: Longtime Abbott CEO resigning; plus Otsuka, Bavarian Nordic, Progenics and Rakuten

Miles White will step down as CEO of Abbott Laboratories (NYSE:ABT) on March 31, after 21 years in the role while remaining executive chairman. President and COO Robert Ford, who joined the company in 1996, will become CEO and has been elected to the board.

Otsuka Pharmaceutical Development & Commercialization Inc. President and CEO William Carson will retire, effective Jan. 1, and become its chairman. A spokesperson for company told BioCentury it has no plans at this time to appoint his successor. OPDC is a subsidiary of Otsuka Pharmaceutical Co. Ltd., itself a subsidiary of Otsuka Holdings Co. Ltd. (Tokyo:4578)...